Glucose excipient is widely used in dental restoration as it enhances the properties of dental materials like acrylics, composites and cements. Glucose excipient helps in improving mechanical properties, hydrophilicity and biocompatibility of these dental materials. It is added as filler in dental acrylics and composites to impart strength, hardness and toughness. Glucose also enhances flowability and workability of dental cements helping in easy application and adaptation to cavity walls. These advantages have led to the increased use of glucose excipient containing dental materials for making customized crowns, bridges, dentures and implants.

The global glucose excipient Market is estimated to be valued at US$ 5,863.3 Mn in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/glucose-excipient-market-5857

Market key trends:

One of the key trends in the glucose excipient market is the development of 3D printed dental materials containing glucose. 3D printing technology has opened new opportunities for customization in dentistry. Major dental material manufacturers are developing glucose based composite resins and cement filaments compatible with various 3D printers. When processed through 3D printers, glucose containing resins and filaments produces final parts with high accuracy, resolution and strength for indicated dental applications. This trend is expected to drive the glucose excipient market as 3D printing becomes more mainstream in dentistry enabling on-demand customized restorations.

Porter’s Analysis

Threat of new entrants: Low- medium. High capital requirements for RD and manufacturing act as a barrier for new players. However, favorable regulations encourage entry of new players.
Bargaining power of buyers: Medium. Large pharmacy chains and hospital networks can negotiate prices. However, need for specialized products limits impact.
Bargaining power of suppliers: Low-Medium. Suppliers of raw materials have moderate influence due to specialized nature of products. Though, availability of substitutes keeps power in check.
Threat of new substitutes: Low-Medium. Glucose based excipients have well-established applications. However, ongoing product innovation can lead to new generation substitutes.
Competitive rivalry: High. The market is growing at a moderate rate with major global players competing on basis of quality, service and cost.

Key Takeaways

The global glucose excipient market is expected to witness high growth over the forecast period driven by increasing pharmaceutical production and new drug development. The global glucose excipient Market is estimated to be valued at US$ 5,863.3 Mn in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030.

Regional analysis: North America dominates the market currently due to presence of major players and focus on innovation. However, Asia Pacific is anticipated to register fastest growth on back of rising healthcare spending, healthcare infrastructure development and growing pharmaceutical industry in China and India.

Key players operating in the glucose excipient market are Polident D.O.O., Amt Medical SRL, Ivoclar Vivadent, VITA Zahnfabrik H. Rauter GmbH Co. KG., Merz Dental GmbH, 3D Diagnostix Inc., Medical Precision Implants, FSM Dental Medikal Mak. San. Tic. Ltd. Sti., Yamahachi Dental Mfg., Co., Glidewell, Anthogyr SAS, Dentsply Sirona, 3Shape, Zimmer Biomet, SprintRay Inc., Thommen Medical AG, Institut Straumann AG, and Henry Schein, Inc. Major players are focusing on product innovation and expansion in emerging regions to strengthen their market position.